BrainStorm Cell Therapeutics
BCLI
#10803
Rank
โ‚ฌ10.47 M
Marketcap
0,95ย โ‚ฌ
Share price
-6.78%
Change (1 day)
46.04%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2026 (TTM): -1,03ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -1,01ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -5,83ย โ‚ฌ an increase over its 2014 EPS that were of -8,80ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,03ย โ‚ฌ
2015-5,83ย โ‚ฌ-33.82%
2014-8,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
8,07ย โ‚ฌ-899.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6,40ย โ‚ฌ-734.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,46ย โ‚ฌ 242.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,90ย โ‚ฌ 484.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
0,86ย โ‚ฌ-185.47%๐Ÿ‡บ๐Ÿ‡ธ USA